SALL1 and acute myeloid leukemia: In order to demonstrate that TBs-(ULBP2-aCD19-aCD33)-treated NK cells also promote a cytotoxic effect against primary AML blasts, three different patient samples were thawed and NK cell cytotoxicity was assessed by FCM analyses.